Many pre-clinical models have shown that eosinophils play a vital role in the tumor microenvironment (TME) and response to immunotherapy through increased expression of CCL5, CXCL9, and CXCL10 [24, 25]. The gene discussed is CXCL10; the disease is neoplasm.